Request Demo
Recent blog posts
Latest Hotspot
8 min read
NCT07715175 Nomelcitinib Renal Insufficiency Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07715175 clinical trial report covering Nomelcitinib, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07715630 Invivo Car-T(Sun-Novo) Relapse multiple myeloma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07715630 clinical trial report covering Invivo Car-T(Sun-Novo), Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07712939 CND-319 Sjogren's Syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07712939 clinical trial report covering CND-319, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07713758 Repinatrabit Phenylketonurias Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07713758 clinical trial report covering Repinatrabit, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07713732 TLN-499 Recurrent Lung Small Cell Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07713732 clinical trial report covering TLN-499, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07714421 Polatuzumab Vedotin-Piiq High grade B-cell lymphoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07714421 clinical trial report covering Polatuzumab Vedotin-Piiq, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07715747 TJ037130 Ovarian Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07715747 clinical trial report covering TJ037130, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07715253 C11-PHNO Schizoaffective disorder Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07715253 clinical trial report covering C11-PHNO, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
NCT07714187 Duvelisib hydrate Mycosis Fungoides Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
NCT07714187 clinical trial report covering Duvelisib hydrate, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262812 Bevacizumab biosimilar (Bio-Thera Solutions) Mismatch repair-deficient Endometrial Carcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262812 clinical trial report covering Bevacizumab biosimilar (Bio-Thera Solutions), Phase 1, endpoints, sponsor, geography, readout timing and develop
Latest Hotspot
8 min read
CTR20262814 ACT201 Hepatitis B, Chronic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262814 clinical trial report covering ACT201, Phase 1, endpoints, sponsor, geography, readout timing and development white space.
Latest Hotspot
8 min read
CTR20262780 JH-013 Primary Sjögren's syndrome Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
3 August 2026
CTR20262780 clinical trial report covering JH-013, Phase 1, endpoints, sponsor, geography, readout timing and development white space.